Gut microbiota profiling: Metabolomics based approach to unravel compounds affecting human health

Frontiers in Microbiology

Volumn 7, Issue JUL, 2016, Pages

  Vernocchi, Pamela ^a   Del Chierico, Federica ^a   Putignani, Lorenza ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Dietary habits; Diseases; Gut microbiota; Metabolome; Omic approach; State of health

Indexed keywords

AMINO ACID; BILE ACID; BIOTIN; CARBOXYLIC ACID; COBALAMIN; LIPID; PANTOTHENIC ACID; POLYPHENOL; RIBOFLAVIN; THIAMINE; VITAMIN; VOLATILE ORGANIC COMPOUND;

CAPILLARY ELECTROPHORESIS; CELIAC DISEASE; CYSTIC FIBROSIS; DIETARY INTAKE; FOOD ALLERGY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATORY BOWEL DISEASE; INFRARED SPECTROSCOPY; INTESTINE FLORA; LIFESTYLE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLOMICS; NEUROPATHOLOGY; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PROTEOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; PUBLIC HEALTH; REVIEW; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84983032316     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.01144     Document Type: Review

References (235)

1. Ahmed, I., Greenwood, R., Costello Bde, L., Ratcliffe, N. M., and Probert, C. S. (2013). An investigation of fecal volatile organic metabolites in irritable bowel syndrome. PLoS ONE 8:e58204. doi: 10.1371/journal.pone.0058204
2. Akhatou, I., González-Domínguez, R., and Fernández-Recamales, Á. (2016). Investigation of the effect of genotype and agronomic conditions on metabolomic profiles of selected strawberry cultivars with different sensitivity to environmental stress. Plant Physiol. Biochem. 101, 14-22. doi: 10.1016/j.plaphy.2016.01.016
3. Alm, L. (1982). Effect of fermentation on B-vitamin content of milk in Sweden. J. Dairy Sci. 65, 353-359. doi: 10.3168/jds.S0022-0302(82)82199-1
4. Alvarez-Sieiro, P., Montalbán-López, M., Mu, D., and Kuipers, O. P. (2016). Bacteriocins of lactic acid bacteria: extending the family. Appl. Microbiol. Biotechnol. 100, 2939-2951. doi: 10.1007/s00253-016-7343-9
5. Amaretti, A., Raimondi, S., Leonardi, A., Quartieri, A., and Rossi, M. (2015). Hydrolysis of the rutinose-conjugates flavonoids rutin and hesperidin by the gut microbiota and bifidobacteria. Nutrients 7, 2788-2800. doi: 10.3390/nu7042788
6. Arora, T., and Sharma, R. (2011). Fermentation potential of the gut microbiome: implications for energy homeostasis and weight management. Nutr. Rev. 69, 99-106. doi: 10.1111/j.1753-4887.2010.00365.x
7. Bacher, A., Eberhardt, S., Fischer, M., Kis, K., and Richter, G. (2000). Biosynthesis of vitamin b2 (riboflavin). Annu. Rev. Nutr. 20, 153-167. doi: 10.1146/annurev.nutr.20.1.153
8. Bacher, A., Eberhardt, S., and Richter, G. (1996). "Biosynthesis of riboflavin," in Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology, ed F. C. Neidhardt (Washington, DC: ASM Press), 657-664.
9. Bakhtiar, R., Ramos, L., and Tse, F. L. S. (2004). Toxicokinetic assessment of methylphenidate (Ritalin) in a 13-week oral toxicity study in dogs. Biomed. Chromatogr. 18, 45-50. doi: 10.1002/bmc.290
10. Barker, M., Hengst, M., Schmid, J., Buers, H.-J., Mittermaier, B., Klemp, D., et al. (2006). Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis. Eur. Respir. J. 27, 929-936. doi: 10.1183/09031936.06.00085105
11. Bathena, S. P., Thakare, R., Gautam, N., Mukherjee, S., Olivera, M., Meza, J., et al. (2015). Urinary bile acids as biomarkers for liver diseases I. Stability of the baseline profile in healthy subjects. Toxicol. Sci. 143, 296-307. doi: 10.1093/toxsci/kfu227
12. Begley, M., Hill, C., and Gahan, C. G. M. (2006). Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 72, 1729-1738. doi: 10.1128/AEM.72.3.1729-1738.2006
13. Belkaid, Y., and Hand, T. W. (2014). Role of the microbiota in immunity and inflammation. Cell 157, 121-141. doi: 10.1016/j.cell.2014.03.011
14. Best, C. A., and Laposata, M. (2003). Fatty acid ethyl esters: toxic non-oxidative metabolites of ethanol and markers of ethanol intake. Front. Biosci. 8, e202-e217. doi: 10.2741/931
15. Binder, H. J. (2010). Role of colonic short-chain fatty acid transport in diarrhea. Annu. Rev. Physiol. 72, 297-313. doi: 10.1146/annurev-physiol-021909-135817
16. Bjerrum, J. T., Wang, Y., Hao, F., Coskun, M., Ludwig, C., Günther, U., et al. (2015). Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics 11, 122-133. doi: 10.1007/s11306-014-0677-3
17. Bone, E., Tamm, A., and Hill, M. (1976). The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer. Am. J. Clin. Nutr. 29, 1448-1454.
18. Bortolini, O., Medici, A., and Poli, S. (1997). Biotransformations on steroid nucleus of bile acids. Steroids 62, 564-577. doi: 10.1016/S0039-128X(97)00043-3
19. Bro, R., Kamstrup-Nielsen, M. H., Engelsen, S. B., Savorani, F., Rasmussen, M. A., Hansen, L., et al. (2015). Forecasting individual breast cancer risk using plasma metabolomics and biocontours. Metabolomics 11, 1376-1380. doi: 10.1007/s11306-015-0793-8
20. Bunge, M., Araghipour, N., Mikoviny, T., Dunkl, J., Schnitzhofer, R., Hansel, A., et al. (2008). On-line monitoring of microbial volatile metabolites by proton transfer reaction-mass spectrometry. Appl. Environ. Microbiol. 74, 2179-2186. doi: 10.1128/AEM.02069-07
21. Calabrò, A., Gralka, E., Luchinat, C., Saccenti, E., and Tenori, L. (2014). A metabolomic perspective on coeliac disease. Autoimmune Dis. 2014:756138. doi: 10.1155/2014/756138
22. Calvani, R., Miccheli, A., Capuani, G., Tomassini Miccheli, A., Puccetti, C., Delfini, M., et al. (2010). Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int. J. Obes. 34, 1095-1098. doi: 10.1038/ijo.2010.44
23. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., et al. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481. doi: 10.2337/db07-1403
24. Cani, P. D., and Delzenne, N. M. (2009). The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des. 15, 1546-1558. doi: 10.2174/138161209788168164
25. Carroll, I. M., Ringel-Kulka, T., Siddle, J. P., and Ringel, Y. (2012). Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil. 24, 521-530, e248. doi: 10.1111/j.1365-2982.2012.01891.x
26. Carterson, A. J., Morici, L. A., Jackson, D. W., Frisk, A., Lizewski, S. E., Jupiter, R., et al. (2004). The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa. J. Bacteriol. 186, 6837-6844. doi: 10.1128/JB.186.20.6837-6844.2004
27. Caspi, R., Foerster, H., Fulcher, C. A., Kaipa, P., Krummenacker, M., Latendresse, M., et al. (2007). The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res. 36, D623-D631. doi: 10.1093/nar/gkm900
28. Catalano, P. M. (2010). Obesity, insulin resistance, and pregnancy outcome. Reproduction 140, 365-371. doi: 10.1530/REP-10-0088
29. Chambers, E. S., Viardot, A., Psichas, A., Morrison, D. J., Murphy, K. G., Zac-Varghese, S. E., et al. (2015). Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64, 1744-1754. doi: 10.1136/gutjnl-2014-307913
30. Chang, C., Guo, Z., He, B., and Yao, W. (2015). Metabolic alterations in the sera of Chinese patients with mild persistent asthma: a GC-MS-based metabolomics analysis. Acta Pharmacol. Sin. 36, 1356-1366. doi: 10.1038/aps.2015.102
31. Chen, J., Zhao, X., Fritsche, J., Yin, P., Schmitt-Kopplin, P., Wang, W., et al. (2008). Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. Anal. Chem. 80, 1280-1289. doi: 10.1021/ac702089h
32. Chow, J., Panasevich, M. R., Alexander, D., Vester Boler, B. M., Rossoni Serao, M. C., Faber, T. A., et al. (2014). Fecal metabolomics of healthy breast-fed versus formula-fed infants before and during in vitro batch culture fermentation. J. Proteome Res. 13, 2534-2542. doi: 10.1021/pr500011w
33. Clayton, T. A. (2012). Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism. FEBS Lett. 586, 956-961. doi: 10.1016/j.febslet.2012.01.049
34. Clifford, M. N. (2004). Diet-derived phenols in plasma and tissues and their implications for health. Planta Med. 70, 1103-1114. doi: 10.1055/s-2004-835835
35. Clinton, S. K., Bostwick, D. G., Olson, L. M., Mangian, H. J., and Visek, W. J. (1988). Effects of ammonium acetate and sodium cholate on N-methyl-N'-nitro-N-nitrosoguanidine-induced colon carcinogenesis of rats. Cancer Res. 48, 3035-3039.
36. Cody, W. L., Pritchett, C. L., Jones, A. K., Carterson, A. J., Jackson, D., Frisk, A., et al. (2009). Pseudomonas aeruginosa AlgR controls cyanide production in an AlgZ-dependent manner. J. Bacteriol. 191, 2993-3002. doi: 10.1128/JB.01156-08
37. Collino, S., Martin, F. P. J., and Rezzi, S. (2012). Clinical Metabolomics paves the way towards future healthcare strategies. Br. J. Clin. Pharmacol. 75, 619-629. doi: 10.1111/j.1365-2125.2012.04216.x
38. Couteau, D., McCartney, A. L., Gibson, G. R., Williamson, G., and Faulds, C. B. (2001). Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J. Appl. Microbiol. 90, 873-881. doi: 10.1046/j.1365-2672.2001.01316.x
39. Cruciani, F., Biagi, E., Severgnini, M., Consolandi, C., Calanni, F., Donders, G., et al. (2015). Development of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis. Antimicrob. Agents Chemother. 59, 2825-2834. doi: 10.1128/AAC.00225-15
40. Currie, F., Broadhurst, D. I., Dunn, W. B., Sellick, C. A., and Goodacre, R. (2016). Metabolomics reveals the physiological response of Pseudomonas putida KT2440 (UWC1) after pharmaceutical exposure. Mol. BioSyst. 12, 1367-1377. doi: 10.1039/C5MB00889A
41. Davidson, R. T., Foley, A. L., Engelke, J. A., and Suttie, J. W. (1998). Conversion of dietary phylloquinone to tissue menaquinone-4 in rats is not dependent on gut bacteria. J. Nutr. 128, 220-223.
42. Dawson, P. A., Lan, T., and Rao, A. (2009). Bile acid transporters. J. Lipid Res. 50, 2340-2357. doi: 10.1194/jlr.R900012-JLR200
43. De Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D. I., et al. (2013). Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS ONE 8:e76993. doi: 10.1371/journal.pone.0076993
44. De Boever, P., Wouters, R., Verschaeve, L., Berckmans, P., Schoeters, G., and Verstraete, W. (2000). Protective effect of the bile salt hydrolase-active Lactobacillus reuteri against bile salt cytotoxicity. Appl. Microbiol. Biotechnol. 53, 709-714. doi: 10.1007/s002530000330
45. De Filippis, F., Pellegrini, N., Vannini, L., Jeffery, I. B., La Storia, A., Laghi, L., et al. (2015). High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. doi: 10.1136/gutjnl-2015-309957. [Epub ahead of print].
46. Deguchi, Y., Morishita, T., and Mutai, M. (1985). comparative studies on synthesis of water-soluble vitamins among human species of bifidobacteria. Agric. Biol. Chem. 49, 13-19.
47. Del Chierico, F., Nobili, V., Vernocchi, P., Russo, A., De Stefanis, C., Gnani, D., et al. (2016). Gut microbiota profiling of pediatric NAFLD and obese patients unveiled by an integrated meta-omics based approach. Hepatology. doi: 10.1002/hep.28572. [Epub ahead of print].
48. Del Chierico, F., Vernocchi, P., Bonizzi, L., Carsetti, R., Castellazzi, A. M., Dallapiccola, B., et al. (2012). Early-life gut microbiota under physiological and pathological conditions: the central role of combined meta-omics-based approaches. J. Proteomics 75, 4580-4587. doi: 10.1016/j.jprot.2012.02.018
49. De Preter, V. (2015). Metabolomics in the clinical diagnosis of inflammatory bowel disease. Dig. Dis. Basel Switz. 33 (Suppl. 1), 2-10. doi: 10.1159/000437033
50. De Preter, V., Joossens, M., Ballet, V., Shkedy, Z., Rutgeerts, P., Vermeire, S., et al. (2013). Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial. Clin. Transl. Gastroenterol. 4, e30. doi: 10.1038/ctg.2012.24
51. De Preter, V., Machiels, K., Joossens, M., Arijs, I., Matthys, C., Vermeire, S., et al. (2015). Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut 64, 447-458. doi: 10.1136/gutjnl-2013-306423
52. De Preter, V., and Verbeke, K. (2013). Metabolomics as a diagnostic tool in gastroenterology. World J. Gastrointest. Pharmacol. Ther. 4, 97-107. doi: 10.4292/wjgpt.v4.i4.97
53. Dettmer, K., Aronov, P. A., and Hammock, B. D. (2007). Mass spectrometry-based metabolomics. Mass Spectrom. Rev. 26, 51-78. doi: 10.1002/mas.20108
54. De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., et al. (2014). Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84-96. doi: 10.1016/j.cell.2013.12.016
55. De Weirdt, R., Possemiers, S., Vermeulen, G., Moerdijk-Poortvliet, T. C. W., Boschker, H. T. S., Verstraete, W., et al. (2010). Human faecal microbiota display variable patterns of glycerol metabolism. FEMS Microbiol. Ecol. 74, 601-611. doi: 10.1111/j.1574-6941.2010.00974.x
56. Di Cagno, R., De Angelis, M., De Pasquale, I., Ndagijimana, M., Vernocchi, P., Ricciuti, P., et al. (2011). Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol. 11:219. doi: 10.1186/1471-2180-11-219
57. Dicksved, J., Halfvarson, J., Rosenquist, M., Järnerot, G., Tysk, C., Apajalahti, J., et al. (2008). Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2, 716-727. doi: 10.1038/ismej.2008.37
58. Ding, X., Yang, S., Li, W., Liu, Y., Li, Z., Zhang, Y., et al. (2014). The potential biomarker panels for identification of major depressive disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis. PLoS ONE 9:e97479. doi: 10.1371/journal.pone.0097479
59. Dole, M. N., Patel, P. A., Sawant, S. D., and Shedpure, P. S. (2011). Advance applications of fourier transform infrared spectroscopy. Int. J. Pharm. Sci. Rev. Res. 7, 159-166.
60. Donohoe, D. R., Garge, N., Zhang, X., Sun, W., O'Connell, T. M., Bunger, M. K., et al. (2011). The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon. Cell Metab. 13, 517-526. doi: 10.1016/j.cmet.2011.02.018
61. Dumas, M. E., Kinross, J., and Nicholson, J. K. (2016). Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. Gastroenterology 146, 46-62. doi: 10.1053/j.gastro.2013.11.001
62. Dunn, W. B., and Ellis, D. I. (2005). Metabolomics: current analytical platforms and methodologies. TrAC Trends Anal. Chem. 24, 285-294. doi: 10.1016/j.trac.2004.11.021
63. Fanos, V., Caboni, P., Corsello, G., Stronati, M., Gazzolo, D., Noto, A., et al. (2014). Urinary 1H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis. Early Hum. Dev. 90, S78-S83. doi: 10.1016/S0378-3782(14)70024-6
64. Fiehn, O., Kopka, J., Dörmann, P., Altmann, T., Trethewey, R. N., and Willmitzer, L. (2000). Metabolite profiling for plant functional genomics. Nat. Biotechnol. 18, 1157-1161. doi: 10.1038/81137
65. Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P., and Forano, E. (2012). Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3, 289-306. doi: 10.4161/gmic.19897
66. Forcisi, S., Moritz, F., Lucio, M., Lehmann, R., Stefan, N., and Schmitt-Kopplin, P. (2015). Solutions for low and high accuracy mass spectrometric data matching: a data-driven annotation strategy in nontargeted metabolomics. Anal. Chem. 87, 8917-8924. doi: 10.1021/acs.analchem.5b02049
67. Francavilla, R., Calasso, M., Calace, L., Siragusa, S., Ndagijimana, M., Vernocchi, P., et al. (2012). Effect of lactose on gut microbiota and metabolome of infants with cow's milk allergy. Pediatr. Allergy Immunol. 23, 420-427. doi: 10.1111/j.1399-3038.2012.01286.x
68. Francavilla, R., Ercolini, D., Piccolo, M., Vannini, L., Siragusa, S., De Filippis, F., et al. (2014). Salivary microbiota and metabolome associated with celiac disease. Appl. Environ. Microbiol. 80, 3416-3425. doi: 10.1128/AEM.00362-14
69. Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., et al. (2011). Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543-547. doi: 10.1038/nature09646
70. Gahleitner, F., Guallar-Hoyas, C., Beardsmore, C. S., Pandya, H. C., and Thomas, C. P. (2013). Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath. Bioanalysis 5, 2239-2247. doi: 10.4155/bio.13.184
71. Gao, Z., Yin, J., Zhang, J., Ward, R. E., Martin, R. J., Lefevre, M., et al. (2009). Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509-1517. doi: 10.2337/db08-1637
72. Garner, C. E., Smith, S., de Lacy Costello, B., White, P., Spencer, R., Probert, C. S. J., et al. (2007). Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 21, 1675-1688. doi: 10.1096/fj.06-6927com
73. Groh, H., Schade, K., and Hörhold-Schubert, C. (1993). Steroid metabolism with intestinal microorganisms. J. Basic Microbiol. 33, 59-72. doi: 10.1002/jobm.3620330115
74. Gromski, P. S., Muhamadali, H., Ellis, D. I., Xu, Y., Correa, E., Turner, M. L., et al. (2015). A tutorial review: metabolomics and partial least squares-discriminant analysis - a marriage of convenience or a shotgun wedding. Anal. Chim. Acta 879, 10-23. doi: 10.1016/j.aca.2015.02.012
75. Guerzoni, M. E., Vernocchi, P., Ndagijimana, M., Gianotti, A., and Lanciotti, R. (2007). Generation of aroma compounds in sourdough: effects of stress exposure and lactobacilli-yeasts interactions. Food Microbiol. 24, 139-148. doi: 10.1016/j.fm.2006.07.007
76. Harig, J. M., Soergel, K. H., Komorowski, R. A., and Wood, C. M. (1989). Treatment of diversion colitis with short-chain-fatty acid irrigation. N. Engl. J. Med. 320, 23-28. doi: 10.1056/NEJM198901053200105
77. Harrigan, G. G., and Goodacre, R. (2003). Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis. Boston, MA: Springer US; Imprint; Springer.
78. Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., and Nicholson, J. K. (2011). Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol. 19, 349-359. doi: 10.1016/j.tim.2011.05.006
79. Holmes, E., Loo, R. L., Stamler, J., Bictash, M., Yap, I. K. S., Chan, Q., et al. (2008). Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453, 396-400. doi: 10.1038/nature06882
80. Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., et al. (2013). Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451-1463. doi: 10.1016/j.cell.2013.11.024
81. Islam, K. B., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., et al. (2011). Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 141, 1773-1781. doi: 10.1053/j.gastro.2011.07.046
82. Jacobs, D. M., Deltimple, N., van Velzen, E., van Dorsten, F. A., Bingham, M., Vaughan, E. E., et al. (2008). (1)H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR Biomed. 21, 615-626. doi: 10.1002/nbm.1233
83. Jaganath, I. B., Mullen, W., Lean, M. E. J., Edwards, C. A., and Crozier, A. (2009). In vitro catabolism of rutin by human fecal bacteria and the antioxidant capacity of its catabolites. Free Radic. Biol. Med. 47, 1180-1189. doi: 10.1016/j.freeradbiomed.2009.07.031
84. Jansson, J., Willing, B., Lucio, M., Fekete, A., Dicksved, J., Halfvarson, J., et al. (2009). Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS ONE 4:e6386. doi: 10.1371/journal.pone.0006386
85. Kamada, N., Chen, G. Y., Inohara, N., and Núñez, G. (2013). Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 14, 685-690. doi: 10.1038/ni.2608
86. Kanehisa, M., Araki, M., Goto, S., Hattori, M., Hirakawa, M., Itoh, M., et al. (2007). KEGG for linking genomes to life and the environment. Nucleic Acids Res. 36, D480-D484. doi: 10.1093/nar/gkm882
87. Keun, H. C., Beckonert, O., Griffin, J. L., Richter, C., Moskau, D., Lindon, J. C., et al. (2002). Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal. Chem. 74, 4588-4593. doi: 10.1021/ac025691r
88. Kidd, P. (2002). Autism, an extreme challenge to integrative medicine. Part: 1: The knowledge base. Altern. Med. Rev. 7, 292-316.
89. Kim, S. J., Kim, S. H., Kim, J. H., Hwang, S., and Yoo, H. J. (2016). Understanding metabolomics in biomedical research. Endocrinol. Metab. Seoul Korea 31, 7-16. doi: 10.3803/EnM.2016.31.1.7
90. Kinross, J. M., Darzi, A. W., and Nicholson, J. K. (2011). Gut microbiome-host interactions in health and disease. Genome Med. 3, 14. doi: 10.1186/gm228
91. Kleerebezem, M., and Vaughan, E. E. (2009). Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu. Rev. Microbiol. 63, 269-290. doi: 10.1146/annurev.micro.091208.073341
92. Kohashi, M., Nishiumi, S., Ooi, M., Yoshie, T., Matsubara, A., Suzuki, M., et al. (2014). A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis. J. Crohns Colitis 8, 1010-1021. doi: 10.1016/j.crohns.2014.01.024
93. Konishi, Y., and Kobayashi, S. (2004). Transepithelial transport of chlorogenic acid, caffeic acid, and their colonic metabolites in intestinal caco-2 cell monolayers. J. Agric. Food Chem. 52, 2518-2526. doi: 10.1021/jf035407c
94. Korithoski, B., Lévesque, C. M., and Cvitkovitch, D. G. (2008). The involvement of the pyruvate dehydrogenase E1alpha subunit, in Streptococcus mutans acid tolerance. FEMS Microbiol. Lett. 289, 13-19. doi: 10.1111/j.1574-6968.2008.01351.x
95. Krajmalnik-Brown, R., Ilhan, Z.-E., Kang, D.-W., and DiBaise, J. K. (2012). Effects of gut microbes on nutrient absorption and energy regulation. Nutr. Clin. Pract. 27, 201-214. doi: 10.1177/0884533611436116
96. Kumar, S., Misra, A., and Ghoshal, U. C. (2010). Patients with irritable bowel syndrome exhale more hydrogen than healthy subjects in fasting state. J. Neurogastroenterol. Motil. 16, 299-305. doi: 10.5056/jnm.2010.16.3.299
97. Kusano, M., Mendez, E., and Furton, K. G. (2013). Comparison of the volatile organic compounds from different biological specimens for profiling potential. J. Forensic Sci. 58, 29-39. doi: 10.1111/j.1556-4029.2012.02215.x
98. Kuzma, J., Nemecek-Marshall, M., Pollock, W. H., and Fall, R. (1995). Bacteria produce the volatile hydrocarbon isoprene. Curr. Microbiol. 30, 97-103. doi: 10.1007/BF00294190
99. Laghi, L., Picone, G., Cruciani, F., Brigidi, P., Calanni, F., Donders, G., et al. (2014). Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. Antimicrob. Agents Chemother. 58, 3411-3420. doi: 10.1128/AAC.02469-14
100. Lambert, M. A., and Moss, C. W. (1980). Production of p-hydroxyhydrocinnamic acid from tyrosine by Peptostreptococcus anaerobius. J. Clin. Microbiol. 12, 291-293.
101. Lamichhane, S., Yde, C. C., Schmedes, M. S., Jensen, H. M., Meier, S., and Bertram, H. C. (2015). Strategy for nuclear-magnetic-resonance-based metabolomics of human feces. Anal. Chem. 87, 5930-5937. doi: 10.1021/acs.analchem.5b00977
102. Leavens, W. J., Lane, S. J., Carr, R. M., Lockie, A. M., and Waterhouse, I. (2002). Derivatization for liquid chromatography/electrospray mass spectrometry: synthesis of tris(trimethoxyphenyl)phosphonium compounds and their derivatives of amine and carboxylic acids. Rapid Commun. Mass Spectrom. 16, 433-441. doi: 10.1002/rcm.559
103. LeBlanc, J. G., Milani, C., de Giori, G. S., Sesma, F., van Sinderen, D., and Ventura, M. (2013). Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr. Opin. Biotechnol. 24, 160-168. doi: 10.1016/j.copbio.2012.08.005
104. Lechner, M., and Rieder, J. (2007). Mass spectrometric profiling of low-molecular-weight volatile compounds-diagnostic potential and latest applications. Curr. Med. Chem. 14, 987-995. doi: 10.2174/092986707780362916
105. Le Gall, G., Colquhoun, I. J., Davis, A. L., Collins, G. J., and Verhoeyen, M. E. (2003). Metabolite profiling of tomato (Lycopersicon esculentum) using 1H NMR spectroscopy as a tool to detect potential unintended effects following a genetic modification. J. Agric. Food Chem. 51, 2447-2456. doi: 10.1021/jf0259967
106. Le Gall, G., Noor, S. O., Ridgway, K., Scovell, L., Jamieson, C., Johnson, I. T., et al. (2011). Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J. Proteome Res. 10, 4208-4218. doi: 10.1021/pr2003598
107. Lenz, E. M., Bright, J., Knight, R., Wilson, I. D., and Major, H. (2004). Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics. J. Pharm. Biomed. Anal. 35, 599-608. doi: 10.1016/j.jpba.2004.02.013
108. Li, L., Hu, L., Han, L.-P., Ji, H., Zhu, Y., Wang, X., et al. (2014). Expression of turtle riboflavin-binding protein represses mitochondrial electron transport gene expression and promotes flowering in Arabidopsis. BMC Plant Biol. 14:381. doi: 10.1186/s12870-014-0381-5
109. Lin, H. V., Frassetto, A., Kowalik, E. J. Jr., Nawrocki, A. R., Lu, M. M., Kosinski, J. R., et al. (2012). Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 7:e35240. doi: 10.1371/journal.pone.0035240
110. Lindon, J. C., Holmes, E., and Nicholson, J. K. (2003). So what's the deal with metabonomics? Anal. Chem. 75, 384A-391A. doi: 10.1021/ac031386+
111. Lis, A. W., McLaughlin, I., Mpclaughlin, R. K., Lis, E. W., and Stubbs, E. G. (1976). Profiles of ultraviolet-absorbing components of urine from autistic children, as obtained by high-resolution ion-exchange chromatography. Clin. Chem. 22, 1528-1532.
112. Liu, J.-Y., Li, N., Yang, J., Li, N., Qiu, H., Ai, D., et al. (2010). Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events. Proc. Natl. Acad. Sci. U.S.A. 107, 17017-17022. doi: 10.1073/pnas.1011278107
113. Lord, R. S., and Bralley, J. A. (2008). Clinical applications of urinary organic acids. Part 2. Dysbiosis markers. Altern. Med. Rev. J. Clin. Ther. 13, 292-306.
114. Louis, P., Hold, G. L., and Flint, H. J. (2014). The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661-672. doi: 10.1038/nrmicro3344
115. Louis, P., Scott, K. P., Duncan, S. H., and Flint, H. J. (2007). Understanding the effects of diet on bacterial metabolism in the large intestine. J. Appl. Microbiol. 102, 1197-1208. doi: 10.1111/j.1365-2672.2007.03322.x
116. Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., and Knight, R. (2012). Diversity, stability and resilience of the human gut microbiota. Nature 489, 220-230. doi: 10.1038/nature11550
117. Macfarlane, G. T., and Gibson, G. R. (2004). "Microbiological aspects of SCFA production in the large bowel," in Physiological and Clinical Aspects of Short-Chain Fatty Acids, eds J. H. Cummings, J. L. Rombeau, and T. Sakata (Cambridge; New York, NY: Cambridge University Press), 87-105.
118. Macfarlane, G. T., and Macfarlane, S. (1997). Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand. J. Gastroenterol. Suppl. 222, 3-9. doi: 10.1080/00365521.1997.11720708
119. Macfarlane, S., and Macfarlane, G. T. (1995). "Proteolysis and amino acid fermentation.," in Human Colonic Bacteria: Role in Nutrition, Physiology, and Pathology, eds G. R. Gibson and G. T. Macfarlane (Boca Raton, FL: CRC press), 75-100.
120. Magnúsdóttir, S., Ravcheev, D., de Crécy-Lagard, V., and Thiele, I. (2015). Systematic genome assessment of B vitamin biosynthesis suggests co-operation among gut microbes. Front Genet. 20:148. doi: 10.3389/fgene.2015.00148
121. Manach, C., Scalbert, A., Morand, C., Rémésy, C., and Jiménez, L. (2004). Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79, 727-747.
122. Marchesi, J. R., Holmes, E., Khan, F., Kochhar, S., Scanlan, P., Shanahan, F., et al. (2007). Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J. Proteome Res. 6, 546-551. doi: 10.1021/pr060470d
123. Marín, L., Miguélez, E. M., Villar, C. J., and Lombó, F. (2015). Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. Biomed Res. Int. 2015:905215. doi: 10.1155/2015/905215
124. Martens, J. H., Barg, H., Warren, M. J., and Jahn, D. (2002). Microbial production of vitamin B12. Appl. Microbiol. Biotechnol. 58, 275-285. doi: 10.1007/s00253-001-0902-7
125. Martin, F.-P. J., Collino, S., Rezzi, S., and Kochhar, S. (2012). Metabolomic applications to decipher gut microbial metabolic influence in health and disease. Front. Physiol. 3:113. doi: 10.3389/fphys.2012.00113
126. Martins-de-Souza, D. (2014). Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder. Dialogues Clin. Neurosci. 16, 63-73.
127. Mayo, B., and van Sinderen, D. (eds.). (2010). Bifidobacteria: Genomics and Molecular Aspects. Norfolk: Caister Academic.
128. Michielan, A., and D'Incà, R. (2015). Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Med. Inflamm. 2015:628157. doi: 10.1155/2015/628157
129. Mills, G. A., and Walker, V. (2001). Headspace solid-phase microextraction profiling of volatile compounds in urine: application to metabolic investigations. J. Chromatogr. B. Biomed. Sci. App. 753, 259-268. doi: 10.1016/S0378-4347(00)00554-5
130. Milne, S. B., Mathews, T. P., Myers, D. S., Ivanova, P. T., and Brown, H. A. (2013). Sum of the parts: mass spectrometry-based metabolomics. Biochemistry (Mosc.) 52, 3829-3840. doi: 10.1021/bi400060e
131. Moco, S., Collino, S., Rezzi, S., and Martin, F.-P. J. (2013). Metabolomics perspectives in pediatric research. Pediatr. Res. 73, 570-576. doi: 10.1038/pr.2013.1
132. Moco, S., Vervoort, J., Moco, S., Bino, R. J., De Vos, R. C. H., and Bino, R. (2007). Metabolomics technologies and metabolite identification. TrAC Trends Anal. Chem. 26, 855-866. doi: 10.1016/j.trac.2007.08.003
133. Montuschi, P., Paris, D., Melck, D., Lucidi, V., Ciabattoni, G., Raia, V., et al. (2012). NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax 67, 222-228. doi: 10.1136/thoraxjnl-2011-200072
134. Moss, C. W., Lambert, M. A., and Goldsmith, D. J. (1970). Production of hydrocinnamic acid by clostridia. Appl. Microbiol. 19, 375-378.
135. Mueller, D. M., Allenspach, M., Othman, A., Saely, C. H., Muendlein, A., Vonbank, A., et al. (2015). Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. Atherosclerosis 243, 638-644. doi: 10.1016/j.atherosclerosis.2015.10.091
136. Mukhopadhya, I., Hansen, R., El-Omar, E. M., and Hold, G. L. (2012). IBD-what role do Proteobacteria play? Nat. Rev. Gastroenterol. Hepatol. 9, 219-230. doi: 10.1038/nrgastro.2012.14
137. Nanda, R., James, R., Smith, H., Dudley, C. R., and Jewell, D. P. (1989). Food intolerance and the irritable bowel syndrome. Gut 30, 1099-1104. doi: 10.1136/gut.30.8.1099
138. Nardotto, G. H. B., Coelho, E. B., Marques, M. P., and Lanchote, V. L. (2016). Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study. J. Chromatogr. B 1015-1016, 173-180. doi: 10.1016/j.jchromb.2016.02.028
139. Nassar, A.-E. F., and Talaat, R. E. (2004). Strategies for dealing with metabolite elucidation in drug discovery and development. Drug Discov. Today 9, 317-327. doi: 10.1016/S1359-6446(03)03018-6
140. Naz, S., Vallejo, M., García, A., and Barbas, C. (2014). Method validation strategies involved in non-targeted metabolomics. J. Chromatogr. A 1353, 99-105. doi: 10.1016/j.chroma.2014.04.071
141. Ndagijimana, M., Laghi, L., Vitali, B., Placucci, G., Brigidi, P., and Guerzoni, M. E. (2009). Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by (1)H Nuclear Magnetic Resonance spectroscopy. Int. J. Food Microbiol. 134, 147-153. doi: 10.1016/j.ijfoodmicro.2009.04.016
142. Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., et al. (2012). Host-gut microbiota metabolic interactions. Science 336, 1262-1267. doi: 10.1126/science.1223813
143. Nicholson, J. K., Holmes, E., and Wilson, I. D. (2005). Opinion: gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 3, 431-438. doi: 10.1038/nrmicro1152
144. Nicholson, J. K., and Lindon, J. C. (2008). Systems biology: metabonomics. Nature 455, 1054-1056. doi: 10.1038/4551054a
145. Noda, H., Akasaka, N., and Ohsugi, M. (1994). Biotin production by bifidobacteria. J. Nutr. Sci. Vitaminol. (Tokyo) 40, 181-188. doi: 10.3177/jnsv.40.181
146. Oresic, M., Simell, S., Sysi-Aho, M., Näntö-Salonen, K., Seppänen-Laakso, T., Parikka, V., et al. (2008). Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J. Exp. Med. 205, 2975-2984. doi: 10.1084/jem.20081800
147. Parkar, S. G., Trower, T. M., and Stevenson, D. E. (2013). Fecal microbial metabolism of polyphenols and its effects on human gut microbiota. Anaerobe 23, 12-19. doi: 10.1016/j.anaerobe.2013.07.009
148. Patrignani, F., Burns, P., Serrazanetti, D., Vinderola, G., Reinheimer, J., Lanciotti, R., et al. (2009). Suitability of high pressure-homogenized milk for the production of probiotic fermented milk containing Lactobacillus paracasei and Lactobacillus acidophilus. J. Dairy Res. 76, 74. doi: 10.1017/S0022029908003828
149. Patrignani, F., Chinnici, F., Serrazanetti, D. I., Vernocchi, P., Ndagijimana, M., Riponi, C., et al. (2016). Production of volatile and sulfur compounds by 10 saccharomyces cerevisiae strains inoculated in trebbiano must. Front. Microbiol. 7:243. doi: 10.3389/fmicb.2016.00243
150. Paul, H. A., Bomhof, M. R., Vogel, H. J., and Reimer, R. A. (2016). Diet-induced changes in maternal gut microbiota and metabolomic profiles influence programming of offspring obesity risk in rats. Sci. Rep. 6:20683. doi: 10.1038/srep20683
151. Pawliszyn, J. (1997). Solid Phase Microextraction: Theory and Practice. New York, NY: Wiley-VCH.
152. Pence, H. E., and Williams, A. (2010). ChemSpider: an online chemical information resource. J. Chem. Educ. 87, 1123-1124. doi: 10.1021/ed100697w
153. Penders, J., Thijs, C., van den Brandt, P. A., Kummeling, I., Snijders, B., Stelma, F., et al. (2007). Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56, 661-667. doi: 10.1136/gut.2006.100164
154. Perkins, N. J., and Pero, J. (2002). "Vitamin biosynthesis," in Bacillus subtilis and Its Closest Relatives from Genes to Cells, eds A. L. Sonenshein, R. Losick, and J. A. Hoch (Washington, DC: ASM Press), 271-286.
155. Phipps, A. N., Stewart, J., Wright, B., and Wilson, I. D. (1998). Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica Fate Foreign Compd. Biol. Syst. 28, 527-537. doi: 10.1080/004982598239443
156. Pisano, M. B., Scano, P., Murgia, A., Cosentino, S., and Caboni, P. (2016). Metabolomics and microbiological profile of Italian mozzarella cheese produced with buffalo and cow milk. Food Chem. 192, 618-624. doi: 10.1016/j.foodchem.2015.07.061
157. Pompei, A., Cordisco, L., Amaretti, A., Zanoni, S., Matteuzzi, D., and Rossi, M. (2007). Folate production by bifidobacteria as a potential probiotic property. Appl. Environ. Microbiol. 73, 179-185. doi: 10.1128/AEM.01763-06
158. Prakash, S., Rodes, L., Coussa-Charley, M., and Tomaro-Duchesneau, C. (2011). Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biol. Targets Ther. 5, 71-86. doi: 10.2147/BTT.S19099
159. Putignani, L., Del Chierico, F., Vernocchi, P., Cicala, M., Cucchiara, S., Dallapiccola, B., et al. (2015). Gut microbiota dysbiosis as risk and premorbid factors of IBD and IBS along the childhood-adulthood transition. Inflamm. Bowel Dis. 22, 487-504. doi: 10.1097/MIB.0000000000000602
160. Qiu, Y., Cai, G., Su, M., Chen, T., Liu, Y., Xu, Y., et al. (2010). Urinary metabonomic study on colorectal cancer. J. Proteome Res. 9, 1627-1634. doi: 10.1021/pr901081y
161. Raamsdonk, L. M., Teusink, B., Broadhurst, D., Zhang, N., Hayes, A., Walsh, M. C., et al. (2001). A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat. Biotechnol. 19, 45-50. doi: 10.1038/83496
162. Raimondi, S., Anighoro, A., Quartieri, A., Amaretti, A., Tomás-Barberán, F. A., Rastelli, G., et al. (2015). Role of bifidobacteria in the hydrolysis of chlorogenic acid. Microbiologyopen 4, 41-52. doi: 10.1002/mbo3.219
163. Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., et al. (2013). Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 11, 868-875.e1-3. doi: 10.1016/j.cgh.2013.02.015
164. Ramautar, R., Somsen, G. W., and de Jong, G. J. (2013). CE-MS for metabolomics: developments and applications in the period 2010-2012. Electrophoresis 34, 86-98. doi: 10.1002/elps.201200390
165. Respondek, F., Gerard, P., Bossis, M., Boschat, L., Bruneau, A., Rabot, S., et al. (2013). Short-chain fructo-oligosaccharides modulate intestinal microbiota and metabolic parameters of humanized gnotobiotic diet induced obesity mice. PLoS ONE 8:e71026. doi: 10.1371/journal.pone.0071026
166. Ridlon, J. M., Kang, D.-J., and Hylemon, P. B. (2006). Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47, 241-259. doi: 10.1194/jlr.R500013-JLR200
167. Robroeks, C. M. H. H. T., van Berkel, J. J. B. N., Dallinga, J. W., Jöbsis, Q., Zimmermann, L. J. I., Hendriks, H. J. E., et al. (2010). Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr. Res. 68, 75-80. doi: 10.1203/PDR.0b013e3181df4ea0
168. Roediger, W. E., Duncan, A., Kapaniris, O., and Millard, S. (1993). Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 104, 802-809. doi: 10.1016/0016-5085(93)91016-B
169. Roessner, U., Wagner, C., Kopka, J., Trethewey, R. N., and Willmitzer, L. (2000). Technical advance: simultaneous analysis of metabolites in potato tuber by gas chromatography-mass spectrometry. Plant J. Cell Mol. Biol. 23, 131-142. doi: 10.1046/j.1365-313x.2000.00774.x
170. Rosselló-Mora, R., Lucio, M., Peña, A., Brito-Echeverría, J., López-López, A., Valens-Vadell, M., et al. (2008). Metabolic evidence for biogeographic isolation of the extremophilic bacterium Salinibacter ruber. ISME J. 2, 242-253. doi: 10.1038/ismej.2007.93
171. Rossi, M., and Amaretti, A. (2010). "Probiotic properties of Bifidobacteria," in Bifidobacteria: Genomics and Molecular Aspects, eds M. Baltasar and D. van Sinderen (Norfolk: Caister Academic), 97-123.
172. Roth, J. R., Lawrence, J. G., and Bobik, T. A. (1996). Cobalamin (coenzyme B12): synthesis and biological significance. Annu. Rev. Microbiol. 50, 137-181. doi: 10.1146/annurev.micro.50.1.137
173. Russell, D. W., and Setchell, K. D. (1992). Bile acid biosynthesis. Biochemistry (Mosc.) 31, 4737-4749. doi: 10.1021/bi00135a001
174. Sabatino, A. D., Morera, R., Ciccocioppo, R., Cazzola, P., Gotti, S., Tinozzi, F. P., et al. (2005). Oral butyrate for mildly to moderately active Crohn's disease. Aliment. Pharmacol. Ther. 22, 789-794. doi: 10.1111/j.1365-2036.2005.02639.x
175. Savorani, F., Rasmussen, M. A., Mikkelsen, M. S., and Engelsen, S. B. (2013). A primer to nutritional metabolomics by NMR spectroscopy and chemometrics. Food Res. Int. 54, 1131-1145. doi: 10.1016/j.foodres.2012.12.025
176. Scalan, P. D., Buckling, A., Kong, W., Wild, Y., Lynch, S. W., and Harrison, F. (2012). Gut dysbiosis in cystic fibrosis. J. Cyst. Fibros. 11, 454-455. doi: 10.1016/j.jcf.2012.03.007
177. Scheppach, W. (1994). Effects of short chain fatty acids on gut morphology and function. Gut 35, S35-S38. doi: 10.1136/gut.35.1_suppl.s35
178. Scheppach, W., Pomare, E. W., Elia, M., and Cummings, J. H. (1991). The contribution of the large intestine to blood acetate in man. Clin. Sci. 80, 177-182. doi: 10.1042/cs0800177
179. Scheppach, W., Sommer, H., Kirchner, T., Paganelli, G. M., Bartram, P., Christl, S., et al. (1992). Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103, 51-56. doi: 10.1016/0016-5085(92)91094-K
180. Schippa, S., Iebba, V., Santangelo, F., Gagliardi, A., De Biase, R. V., Stamato, A., et al. (2013). Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients. PLoS ONE 8:e61176. doi: 10.1371/journal.pone.0061176
181. Schöller, C., Molin, S., and Wilkins, K. (1997). Volatile metabolites from some gram-negative bacteria. Chemosphere 35, 1487-1495. doi: 10.1016/S0045-6535(97)00209-9
182. Scholtens, D. M., Muehlbauer, M. J., Daya, N. R., Stevens, R. D., Dyer, A. R., Lowe, L. P., et al. (2014). Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy. Diabetes Care 37, 158-166. doi: 10.2337/dc13-0989
183. Selma, M. V., Espín, J. C., and Tomás-Barberán, F. A. (2009). Interaction between phenolics and gut microbiota: role in human health. J. Agric. Food Chem. 57, 6485-6501. doi: 10.1021/jf902107d
184. Shahani, K. M., and Chandan, R. C. (1979). Nutritional and healthful aspects of cultured and culture-containing dairy foods. J. Dairy Sci. 62, 1685-1694. doi: 10.3168/jds.S0022-0302(79)83481-5
185. Silla Santos, M. H. (1996). Biogenic amines: their importance in foods. Int. J. Food Microbiol. 29, 213-231. doi: 10.1016/0168-1605(95)00032-1
186. Siroli, L., Patrignani, F., Serrazanetti, D. I., Tabanelli, G., Montanari, C., Gardini, F., et al. (2015). Lactic acid bacteria and natural antimicrobials to improve the safety and shelf-life of minimally processed sliced apples and lamb's lettuce. Food Microbiol. 47, 74-84. doi: 10.1016/j.fm.2014.11.008
187. Sivsammye, G., and Sims, H. V. (1990). Presumptive identification of Clostridium difficile by detection of p-cresol in prepared peptone yeast glucose broth supplemented with p-hydroxyphenylacetic acid. J. Clin. Microbiol. 28, 1851-1853.
188. Smirnov, K. S., Maier, T. V., Walker, A., Heinzmann, S. S., Forcisi, S., Martinez, I., et al. (2016). Challenges of metabolomics in human gut microbiota research. Int. J. Med. Microbiol. doi: 10.1016/j.ijmm.2016.03.006. [Epub ahead of print].
189. Smith, A. G., Croft, M. T., Moulin, M., and Webb, M. E. (2007). Plants need their vitamins too. Curr. Opin. Plant Biol. 10, 266-275. doi: 10.1016/j.pbi.2007.04.009
190. Smith, C. A., O'Maille, G., Want, E. J., Qin, C., Trauger, S. A., Brandon, T. R., et al. (2005). METLIN: a metabolite mass spectral database. Ther. Drug Monit. 27, 747-751. doi: 10.1097/01.ftd.0000179845.53213.39
191. Smith, E. A., and Macfarlane, G. T. (1997). Dissimilatory amino Acid metabolism in human colonic bacteria. Anaerobe 3, 327-337. doi: 10.1006/anae.1997.0121
192. Smolinska, A., Blanchet, L., Buydens, L. M. C., and Wijmenga, S. S. (2012). NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal. Chim. Acta 750, 82-97. doi: 10.1016/j.aca.2012.05.049
193. Soga, T., Ohashi, Y., Ueno, Y., Naraoka, H., Tomita, M., and Nishioka, T. (2003). Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J. Proteome Res. 2, 488-494. doi: 10.1021/pr034020m
194. Srinivasan, S., Morgan, M. T., Fiedler, T. L., Djukovic, D., Hoffman, N. G., Raftery, D., et al. (2015). Metabolic signatures of bacterial vaginosis. MBio 6, e00204-e00215. doi: 10.1128/mBio.00204-15
195. Stanton, C., Ross, R. P., Fitzgerald, G. F., and Van Sinderen, D. (2005). Fermented functional foods based on probiotics and their biogenic metabolites. Curr. Opin. Biotechnol. 16, 198-203. doi: 10.1016/j.copbio.2005.02.008
196. Stashenko, E. E., Jaramillo, B. E., and Martínez, J. R. (2004). Analysis of volatile secondary metabolites from Colombian Xylopia aromatica (Lamarck) by different extraction and headspace methods and gas chromatography. J. Chromatogr. A 1025, 105-113. doi: 10.1016/j.chroma.2003.10.059
197. Stephens, N. S., Siffledeen, J., Su, X., Murdoch, T. B., Fedorak, R. N., and Slupsky, C. M. (2013). Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy. J. Crohns Colitis 7, e42-e48. doi: 10.1016/j.crohns.2012.04.019
198. Sugawara, T., Sawada, D., Ishida, Y., Aihara, K., Aoki, Y., Takehara, I., et al. (2016). Regulatory effect of paraprobiotic Lactobacillus gasseri CP2305 on gut environment and function. Microb. Ecol. Health Dis. 27:30259. doi: 10.3402/mehd.v27.30259
199. Suhre, K., Meisinger, C., Döring, A., Altmaier, E., Belcredi, P., Gieger, C., et al. (2010). Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 5:e13953. doi: 10.1371/journal.pone.0013953
200. Suttie, J. W. (1995). The importance of menaquinones in human nutrition. Annu. Rev. Nutr. 15, 399-417. doi: 10.1146/annurev.nu.15.070195.002151
201. Tabanelli, G., Bargossi, E., Gardini, A., Lanciotti, R., Magnani, R., Gardini, F., et al. (2015a). Physico-chemical and microbiological characterisation of Italian fermented sausages in relation to their size: Italian fermented sausages characterisation. J. Sci. Food Agric. 96, 2773-2781. doi: 10.1002/jsfa.7442
202. Tabanelli, G., Vernocchi, P., Patrignani, F., Del Chierico, F., Putignani, L., Vinderola, G., et al. (2015b). Effects of sub-lethal high-pressure homogenization treatment on the outermost cellular structures and the volatile-molecule profiles of two strains of probiotic lactobacilli. Front. Microbiol. 6:1006. doi: 10.3389/fmicb.2015.01006
203. Taverniti, V., and Guglielmetti, S. (2012). Health-promoting properties of Lactobacillus helveticus. Front. Microbiol. 3:392. doi: 10.3389/fmicb.2012.00392
204. Vaidyanathan, S., Kell, D. B., and Goodacre, R. (2002). Flow-injection electrospray ionization mass spectrometry of crude cell extracts for high-throughput bacterial identification. J. Am. Soc. Mass Spectrom. 13, 118-128. doi: 10.1016/S1044-0305(01)00339-7
205. Vannini, L., Patrignani, F., Iucci, L., Ndagijimana, M., Vallicelli, M., Lanciotti, R., et al. (2008). Effect of a pre-treatment of milk with high pressure homogenization on yield as well as on microbiological, lipolytic and proteolytic patterns of "Pecorino" cheese. Int. J. Food Microbiol. 128, 329-335. doi: 10.1016/j.ijfoodmicro.2008.09.018
206. van Zanten, G. C., Krych, L., Röytiö, H., Forssten, S., Lahtinen, S. J., Al-Soud, W. A., et al. (2014). Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial. FEMS Microbiol. Ecol. 90, 225-236. doi: 10.1111/1574-6941.12397
207. Velázquez, O. C., Lederer, H. M., and Rombeau, J. L. (1997). Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications. Adv. Exp. Med. Biol. 427, 123-134. doi: 10.1007/978-1-4615-5967-2_14
208. Vernocchi, P., Ndagijimana, M., Serrazanetti, D. I., López, C. C., Fabiani, A., Gardini, F., et al. (2011). Use of Saccharomyces cerevisiae strains endowed with β-glucosidase activity for the production of Sangiovese wine. World J. Microbiol. Biotechnol. 27, 1423-1433. doi: 10.1007/s11274-010-0594-1
209. Vernocchi, P., Vannini, L., Gottardi, D., Del Chierico, F., Serrazanetti, D. I., Ndagijimana, M., et al. (2012). Integration of datasets from different analytical techniques to assess the impact of nutrition on human metabolome. Front. Cell. Infect. Microbiol. 2:156. doi: 10.3389/fcimb.2012.00156
210. Veselkov, K. A., Lindon, J. C., Ebbels, T. M. D., Crockford, D., Volynkin, V. V., Holmes, E., et al. (2009). Recursive segment-wise peak alignment of biological (1)h NMR spectra for improved metabolic biomarker recovery. Anal. Chem. 81, 56-66. doi: 10.1021/ac8011544
211. Villas-Bôas, S. G., Mas, S., Akesson, M., Smedsgaard, J., and Nielsen, J. (2005). Mass spectrometry in metabolome analysis. Mass Spectrom. Rev. 24, 613-646. doi: 10.1002/mas.20032
212. Villaseñor, A., Kinross, J. M., Li, J. V., Penney, N., Barton, R. H., Nicholson, J. K., et al. (2014). 1H NMR global metabolic phenotyping of acute pancreatitis in the emergency unit. J. Proteome Res. 5, 362-375. doi: 10.1021/pr500161w
213. Vitali, B., Cruciani, F., Picone, G., Parolin, C., Donders, G., and Laghi, L. (2015). Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis. Eur. J. Clin. Microbiol. Infect. Dis. 34, 2367-2376. doi: 10.1007/s10096-015-2490-y
214. Vitali, B., Ndagijimana, M., Cruciani, F., Carnevali, P., Candela, M., Guerzoni, M. E., et al. (2010). Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol. 10:4. doi: 10.1186/1471-2180-10-4
215. Vitali, B., Ndagijimana, M., Maccaferri, S., Biagi, E., Guerzoni, M. E., and Brigidi, P. (2012). An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota. Anaerobe 18, 386-391. doi: 10.1016/j.anaerobe.2012.04.014
216. Vitali, B., Pugliese, C., Biagi, E., Candela, M., Turroni, S., Bellen, G., et al. (2007). Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl. Environ. Microbiol. 73, 5731-5741. doi: 10.1128/AEM.01251-07
217. Walker, A., Lucio, M., Pfitzner, B., Scheerer, M. F., Neschen, S., de Angelis, M. H., et al. (2014). Importance of sulfur-containing metabolites in discriminating fecal extracts between normal and type-2 diabetic mice. J. Proteome Res. 13, 4220-4231. doi: 10.1021/pr500046b
218. Walton, C., Fowler, D. P., Turner, C., Jia, W., Whitehead, R. N., Griffiths, L., et al. (2013). Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm. Bowel Dis. 19, 2069-2078. doi: 10.1097/MIB.0b013e31829a91f6
219. Wang, T., Carroll, W., Lenny, W., Boit, P., and Smith, D. (2006). The analysis of 1-propanol and 2-propanol in humid air samples using selected ion flow tube mass spectrometry. Rapid Commun. Mass Spectrom. 20, 125-130. doi: 10.1002/rcm.2285
220. Watanabe, S., Narisawa, Y., Arase, S., Okamatsu, H., Ikenaga, T., Tajiri, Y., et al. (2003). Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J. Allergy Clin. Immunol. 111, 587-591. doi: 10.1067/mai.2003.105
221. Weckwerth, W., and Morgenthal, K. (2005). Metabolomics: from pattern recognition to biological interpretation. Drug Discov. Today 10, 1551-1558. doi: 10.1016/S1359-6446(05)03609-3
222. Williams, H. R. T., Cox, I. J., Walker, D. G., Cobbold, J. F. L., Taylor-Robinson, S. D., Marshall, S. E., et al. (2010). Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease. BMC Gastroenterol. 10:108. doi: 10.1186/1471-230X-10-108
223. Wilson, M. (2005). Microbial Inhabitants of Human. Cambridge; New York, NY: Cambridge University Press.
224. Wishart, D. S., Jewison, T., Guo, A. C., Wilson, M., Knox, C., Liu, Y., et al. (2013). HMDB 3.0-the human metabolome database in 2013. Nucleic Acids Res. 41, D801-D807. doi: 10.1093/nar/gks1065
225. Wissenbach, D. K., Oliphant, K., Rolle-Kampczyk, U., Yen, S., Höke, H., Baumann, S., et al. (2016). Optimization of metabolomics of defined in vitro gut microbial ecosystems. Int. J. Med. Microbiol. doi: 10.1016/j.ijmm.2016.03.007. [Epub ahead of print].
226. Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A., and Jenkins, D. J. A. (2006). Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40, 235-243. doi: 10.1097/00004836-200603000-00015
227. Worley, B., and Powers, R. (2012). Multivariate analysis in metabolomics. Curr. Metabolomics 1, 92-107. doi: 10.2174/2213235x11301010092
228. Yamashita, H., Fujisawa, K., Ito, E., Idei, S., Kawaguchi, N., Kimoto, M., et al. (2007). Improvement of obesity and glucose tolerance by acetate in type 2 diabetic otsuka long-evans tokushima fatty (OLETF) rats. Biosci. Biotechnol. Biochem. 71, 1236-1243. doi: 10.1271/bbb.60668
229. Zamboni, N., Saghatelian, A., and Patti, G. J. (2015). Defining the metabolome: size, flux, and regulation. Mol. Cell 58, 699-706. doi: 10.1016/j.molcel.2015.04.021
230. Zhang, G., Bai, H., Zhang, H., Dean, C., Wu, Q., Li, J., et al. (2011). Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron 69, 523-535. doi: 10.1016/j.neuron.2010.12.036
231. Zhang, A., Sun, H., and Wang, X. (2012). Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment. Appl. Biochem. Biotechnol. 168, 1718-1727. doi: 10.1007/s12010-012-9891-5
232. Zhang, C., Yin, A., Li, H., Wang, R., Wu, G., Shen, J., et al. (2015). Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children. EBioMedicine 2, 966-982. doi: 10.1016/j.ebiom.2015.07.007
233. Zhao, L., and Hartung, T. (2015). Metabonomics and toxicology. Methods Mol. Biol. Clifton NJ 1277, 209-231. doi: 10.1007/978-1-4939-2377-9_15
234. Zhao, L., Liu, X., Xie, L., Gao, H., and Lin, D. (2010). 1H NMR-based metabonomic analysis of metabolic changes in streptozotocin-induced diabetic rats. Anal. Sci. Int. J. Jpn. Soc. Anal. Chem. 26, 1277-1282. doi: 10.2116/analsci.26.1277
235. Zheng, X., Xie, G., Zhao, A., Zhao, L., Yao, C., Chiu, N. H. L., et al. (2011). The footprints of gut microbial-mammalian co-metabolism. J. Proteome Res. 10, 5512-5522. doi: 10.1021/pr2007945